Dr. Carl Edward Orringer, MD

Dr. Orringer practices at NCHMD Inc in Naples, Florida.

Dr. Orringer's NPI, 1053404350, was assigned on October 2, 2006. Dr. Orringer graduated from University of Miami, Miller School of Medicine in 1974. Dr. Orringer holds Florida license ME 118664.

Dr. Orringer's primary practice is NCHMD Inc, at 801 Vanderbilt Beach Rd, Naples, FL 34108 in Collier County. The practice phone is (239) 624-6338.

Dr. Orringer's primary practice is NCHMD Inc in Naples, Florida. Dr. Orringer is also affiliated with NCH Baker Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Orringer to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orringer practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Orringer's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Orringer is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Orringer's licenses on file in 4 states: Florida, Ohio, Michigan and Louisiana.

Dmand AI lists aneurysm, atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart valve disorders, high cholesterol and sick sinus syndrome among the conditions Dr. Orringer treats.

CMS data shows 481 Medicare services from Dr. Orringer across 6 procedure codes in 2024, for 277 Medicare patients. Medicare paid $37,203 for them. Every service was in an office.

CMS counts 277 Medicare patients who saw Dr. Orringer in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Orringer's median patient age at 70, with 41% women.

In 2024, Dr. Orringer wrote 630 Medicare Part D claims for 240 patients. 81% of them were for generic drugs. CMS names the drug for 540 of them, across 11 drugs with 11 or more claims each, at $72,769 in total drug cost. In 2023, CMS named 1,392 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Orringer for performance year 2024, reported through an alternative payment model (APM). Dr. Orringer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 58 papers to Dr. Orringer, published from 2010 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases and Atherosclerosis. Dr. Orringer has published most often in J Clin Lipidol. Dr. Orringer's most frequent co-authors are Terry A. Jacobson, MD, Salim S. Virani, MD and Roger Scott Blumenthal, MD.

CMS Open Payments shows 17 general payments to Dr. Orringer from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. ShockWave Medical, Inc paid the most, $168.

Dmand AI lists 1 award for Dr. Orringer.

Dr. Orringer graduated from University of Miami, Miller School of Medicine in 1974. Dr. Orringer is a member of ACC.

Dr. Orringer is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.